使用化妆品改善痤疮护理:一个新术语的介绍和文献综述。

IF 1.5 4区 医学 Q3 DERMATOLOGY
Hilary Baldwin, Helen Bui, Valerie Callender, Cheri Frey, Adelaide Hebert, Edward Ted, Evan Rieder, Todd Schlesinger
{"title":"使用化妆品改善痤疮护理:一个新术语的介绍和文献综述。","authors":"Hilary Baldwin, Helen Bui, Valerie Callender, Cheri Frey, Adelaide Hebert, Edward Ted, Evan Rieder, Todd Schlesinger","doi":"10.36849/JDD.8817","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generally involves the use of pharmaceutical agents and procedural techniques. Recently, the importance of over-the-counter skin care in acne has been recognized in many studies. This paper introduces the term acneceuticals to encompass a wide range of FDA- monographed, yet non-prescription ingredients proven to alter the structure and function of acneic skin.</p><p><strong>Methods: </strong>A panel of 8 dermatologists with an interest in acne and skin care performed a literature review of active skin care in acne. The role of acneceuticals in the treatment of acne - as monotherapy, adjunctive, and maintenance therapy - was evaluated using a modified Delphi approach. Studies were limited to in vivo human trials involving acne. Individual actives were assessed separately.</p><p><strong>Results: </strong>The quality of evidence was moderate-to-low for many of the ingredients. Most of the actives included in the final assessment had been studied in vehicle-controlled, blinded, often comparative studies but enrolled a small number of subjects. In these studies, the acneceuticals were found to reduce lesion count, reduce sebum production, and improve efficacy of existing pharmacologic therapies.</p><p><strong>Conclusion: </strong>Acneceuticals have demonstrated benefits in treating acne, alone or in conjunction with established pharmaceutical agents. These data allow us to make quality recommendations for our patients that should be a part of every patient encounter. The recommendations also serve as a guide for patients searching the internet for beneficial self-care products. J Drugs Dermatol. 2025;24(3):281-288. doi:10.36849/JDD.8817.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"24 3","pages":"281-288"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature.\",\"authors\":\"Hilary Baldwin, Helen Bui, Valerie Callender, Cheri Frey, Adelaide Hebert, Edward Ted, Evan Rieder, Todd Schlesinger\",\"doi\":\"10.36849/JDD.8817\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generally involves the use of pharmaceutical agents and procedural techniques. Recently, the importance of over-the-counter skin care in acne has been recognized in many studies. This paper introduces the term acneceuticals to encompass a wide range of FDA- monographed, yet non-prescription ingredients proven to alter the structure and function of acneic skin.</p><p><strong>Methods: </strong>A panel of 8 dermatologists with an interest in acne and skin care performed a literature review of active skin care in acne. The role of acneceuticals in the treatment of acne - as monotherapy, adjunctive, and maintenance therapy - was evaluated using a modified Delphi approach. Studies were limited to in vivo human trials involving acne. Individual actives were assessed separately.</p><p><strong>Results: </strong>The quality of evidence was moderate-to-low for many of the ingredients. Most of the actives included in the final assessment had been studied in vehicle-controlled, blinded, often comparative studies but enrolled a small number of subjects. In these studies, the acneceuticals were found to reduce lesion count, reduce sebum production, and improve efficacy of existing pharmacologic therapies.</p><p><strong>Conclusion: </strong>Acneceuticals have demonstrated benefits in treating acne, alone or in conjunction with established pharmaceutical agents. These data allow us to make quality recommendations for our patients that should be a part of every patient encounter. The recommendations also serve as a guide for patients searching the internet for beneficial self-care products. J Drugs Dermatol. 2025;24(3):281-288. doi:10.36849/JDD.8817.</p>\",\"PeriodicalId\":15566,\"journal\":{\"name\":\"Journal of Drugs in Dermatology\",\"volume\":\"24 3\",\"pages\":\"281-288\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drugs in Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.36849/JDD.8817\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8817","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:痤疮是一种多因素炎症性皮肤状况,通常出现在皮肤科诊所。治疗通常包括使用药物和程序技术。最近,在许多研究中已经认识到非处方护肤对痤疮的重要性。本文介绍的术语消痘药包括广泛的FDA专著,但非处方成分证明改变结构和功能的痤疮皮肤。方法:一个由8位对痤疮和皮肤护理感兴趣的皮肤科医生组成的小组对痤疮的主动皮肤护理进行了文献综述。祛痘药在痤疮治疗中的作用-作为单一疗法,辅助疗法和维持疗法-使用改进的德尔菲方法进行评估。研究仅限于涉及痤疮的体内人体试验。单独评估个体活动。结果:许多成分的证据质量为中低。最终评估中包括的大多数活动都是在车辆对照、盲法研究中进行的,通常是比较研究,但只招募了少数受试者。在这些研究中,发现这些药物可以减少病变计数,减少皮脂的产生,并提高现有药物治疗的疗效。结论:痤疮药已经证明了治疗痤疮的好处,单独或与已建立的药物制剂联合使用。这些数据使我们能够为患者提供高质量的建议,这些建议应该是每个患者就诊的一部分。这些建议还可以作为患者在互联网上搜索有益的自我护理产品的指南。医学与皮肤杂志,2025;24(3):281-288。doi: 10.36849 / JDD.8817。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature.

Background: Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generally involves the use of pharmaceutical agents and procedural techniques. Recently, the importance of over-the-counter skin care in acne has been recognized in many studies. This paper introduces the term acneceuticals to encompass a wide range of FDA- monographed, yet non-prescription ingredients proven to alter the structure and function of acneic skin.

Methods: A panel of 8 dermatologists with an interest in acne and skin care performed a literature review of active skin care in acne. The role of acneceuticals in the treatment of acne - as monotherapy, adjunctive, and maintenance therapy - was evaluated using a modified Delphi approach. Studies were limited to in vivo human trials involving acne. Individual actives were assessed separately.

Results: The quality of evidence was moderate-to-low for many of the ingredients. Most of the actives included in the final assessment had been studied in vehicle-controlled, blinded, often comparative studies but enrolled a small number of subjects. In these studies, the acneceuticals were found to reduce lesion count, reduce sebum production, and improve efficacy of existing pharmacologic therapies.

Conclusion: Acneceuticals have demonstrated benefits in treating acne, alone or in conjunction with established pharmaceutical agents. These data allow us to make quality recommendations for our patients that should be a part of every patient encounter. The recommendations also serve as a guide for patients searching the internet for beneficial self-care products. J Drugs Dermatol. 2025;24(3):281-288. doi:10.36849/JDD.8817.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
289
审稿时长
3-6 weeks
期刊介绍: The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信